DAWN — DAY ONE BIOPHARMACEUTICALS I

Ownership history in Dynamic Technology Lab Private Ltd  ·  7 quarters on record

This page tracks every 13F SEC filing in which Dynamic Technology Lab Private Ltd reported a position in DAY ONE BIOPHARMACEUTICALS I (DAWN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.1% (2025 Q3)
Avg. % of fund
0.05%
First filed
2023 Q1
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 87,541 +4,318 +5.2% 0.10% $618K $7.05
2025 Q2 ADDED 83,223 +34,766 +71.7% 0.07% $541K $6.50
2025 Q1 ADDED 48,457 +35,983 +288.5% 0.06% $384K $7.93
2024 Q3 ADDED 12,474 +1,823 +17.1% 0.02% $174K $13.93
2023 Q4 REDUCED 10,651 -12,704 -54.4% 0.02% $156K $14.60
2023 Q2 REDUCED 23,355 -17,796 -43.2% 0.04% $279K $11.94
2023 Q1 INITIATED 41,151 — — 0.05% $550K $13.37
% of Fund (quarterly)    DAWN price (monthly, adj. close)

Other funds also holding DAWN

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 6.91% AIGH Capital Management LLC 3Y 4.49% DAFNA Capital Management LLC 3Y 7Y 2.16% Lion Point Capital, LP 3Y 7Y 2.03% Vestal Point Capital, LP 1.65% Stonepine Capital Management, LLC 3Y 7Y 1.36% MAK CAPITAL ONE LLC 3Y 7Y 0.85% PERKINS CAPITAL MANAGEMENT INC 3Y 7Y 0.62% Parkman Healthcare Partners LLC 3Y 0.57% ORACLE INVESTMENT MANAGEMENT INC 3Y 7Y 0.55%
← Back to Dynamic Technology Lab Private Ltd Holdings